drugset / Trial / NCT01816646

Intravesical Cidofovir for Hemorrhagic Cystitis

NCT01816646

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn how the drug cidofovir given as 1 dose directly into the bladder is absorbed by the body. Researchers also want to measure the amount of study drug in the body at different time points. The safety and tolerability of this drug will also be studied. Cidofovir is designed to fight certain viruses by blocking the virus cells from dividing.

Timeline

Start
2013-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CIDOFOVIR ANHYDROUS Small molecule 2.5 mg/kg Other
Background Probenecid Small molecule 2 g Oral